T Cells Archives - Page 2 of 2 - Australian Biotech Company News

Home Tags T Cells

Biotechnology

Brain Cancer CAR T Cell Therapy Guided by Scorpion Toxin Starts...

BioChannel - March 6, 2020

Biotechnology

GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration

BioChannel - February 20, 2020

Biotechnology

Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics

BioChannel - January 28, 2020

Biotechnology

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

BioChannel - January 23, 2020

Biotechnology

Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline

BioChannel - December 27, 2019

Biotechnology

“Squeezing” Cells Could Transform Cell Therapy Manufacturing

BioChannel - November 19, 2019

Biotechnology

Celgene, Immatics Launch Up-to-$1.5B+ Cancer T-Cell Collaboration

BioChannel - August 28, 2019

Biotechnology

Q&A: Evolution of CAR-T Cell Therapy and Future Directions

BioChannel - July 5, 2019

Biotechnology

Polyfunctional Strength Offers a New Approach to Defining Quality in Cell...

BioChannel - May 31, 2019

Biotechnology

Crafting a More Efficient CAR T-Cell Industry

BioChannel - May 1, 2019

12Page 2 of 2

Stay connected

Recent posts

Researchers create first comprehensive functional map of genes expressed in human cells

BioChannel - June 9, 2022

Are we born with a moral compass?

BioChannel - June 9, 2022

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods

BioChannel - June 9, 2022

Random article

Researchers create first comprehensive functional map of genes expressed in human...

Are we born with a moral compass?

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery...

Alzheimer’s Pathology Could Benefit from Activating Microglial Targets of Rapamycin